What is the role of cytogenetic and molecular genetic analysis in the diagnosis of chronic myeloproliferative disorders?

被引:2
作者
Owen, RG [1 ]
Dickinson, H
Evans, PAS
O'Connor, SJM
Swirsky, DM
Jack, AS
机构
[1] Univ Leeds, Teaching Hosp NHS Trust, Haematol Malignancy Diagnost Serv, Leeds, W Yorkshire, England
[2] Univ Leeds, Teaching Hosp NHS Trust, Dept Cytogenet, Leeds, W Yorkshire, England
关键词
bcr-abl; cytogenetics; myeloproliferative disorders;
D O I
10.1046/j.1365-2141.2003.04132_2.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:717 / 718
页数:2
相关论文
共 7 条
[1]  
CORRADINI P, 1990, HAEMATOLOGICA, V75, P573
[2]   Typical essential thrombocythaemia does not express bcr-abelson fusion transcript [J].
Damaj, G ;
Delabesse, E ;
Le Bihan, C ;
Asnafi, V ;
Rachid, M ;
Lefrère, F ;
Radford-Weiss, I ;
Macintyre, E ;
Hermine, O ;
Varet, B .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (04) :812-816
[3]  
Jaffe E.S., 2001, PATHOLOGY GENETICS T, V3
[4]   CYTOGENETIC ABNORMALITIES AND LEUKEMIC TRANSFORMATION IN HYDROXYUREA-TREATED PATIENTS WITH PHILADELPHIA-CHROMOSOME NEGATIVE CHRONIC MYELOPROLIFERATIVE DISEASE [J].
LOFVENBERG, E ;
NORDENSON, I ;
WAHLIN, A .
CANCER GENETICS AND CYTOGENETICS, 1990, 49 (01) :57-67
[5]  
Murphy S, 1999, SEMIN HEMATOL, V36, P9
[6]  
RICHARDS EM, 1993, BRIT J HAEMATOL, V85, P625
[7]   CLINICAL PRESENTATION AND NATURAL-HISTORY OF PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND THE PHILADELPHIA-CHROMOSOME [J].
STOLL, DB ;
PETERSON, P ;
EXTEN, R ;
LASZLO, J ;
PISCIOTTA, AV ;
ELLIS, JT ;
WHITE, P ;
VAIDYA, K ;
BOZDECH, M ;
MURPHY, S .
AMERICAN JOURNAL OF HEMATOLOGY, 1988, 27 (02) :77-83